Anterra Capital Holds Initial Close On Second Food And Agriculture Technology Fund
Food and agriculture specialist venture capital firm Anterra Capital has held the initial closing of its second food and agriculture technology fund, Anterra F&A Ventures II, raising $175mn, exceeding the targeted size of the fund. Anterra anticipates a final closing in the third quarter, 2021.
Investors signed up so far include Eight Roads Ventures (backed by Fidelity); Rabo Investments, the captive investment arm of Netherlands-based Rabobank; Novo Holdings; Tattarang; and the holding company of the Forrest family’s private business interests.
“The food economy is in critical condition, and new digital and biotech solutions are desperately needed in order to support better outcomes for farmers, consumers and the environment,” said Adam Anders, Managing Partner of Anterra Capital. “With the first close, we continue our mission to sustainably transform our food economy, building on our leadership position as an early-stage investor in markets such as plant and animal health, while actively expanding our investment activity across the food and agriculture value chain.”
Daniel Auerbach, Senior Managing Partner and Global Head of Eight Roads Ventures, one of Anterra’s original lead investors, added: “Within Food & Ag, Anterra sits at the intersection of life sciences and digital technology and our expanded investment reflects our confidence in Anterra’s mission, leadership and performance for us over the past eight years.”
“We are excited to partner with Anterra and support the fund’s transformational mission, which is aligned with our investment activity across the biotech space overall, and emphasizes our commitment to investing in innovation within Food & Agriculture” said Kartik Dharmadhikari, a Partner of Novo Growth within Novo Holdings.
© The Sortino Group Ltd
All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or scanning or otherwise, except under the terms of the Copyright, Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency or other Reprographic Rights Organisation, without the written permission of the publisher. For more information about reprints from AlphaWeek, click here.